Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC as Adjuvant Therapy for HIV-Associated Tuberculosis
NCT03281226Phase 2Unknown
- Sponsor
- Fundação de Medicina Tropical Dr. Heitor Vieira Dourado
- Start
- Dec 2016
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in Tuberculosis (TB), sponsored by Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Status: unknown.
02
Drugs
acetylcysteine
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT03281226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03281226.